アイテム詳細

要旨

The importance of genomic surveillance strategies for pathogens has been particularly evident during the coronavirus disease 2019 (COVID-19) pandemic, as genomic data from the causative agent, severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), have guided public health decisions worldwide. Bayesian phylodynamic inference, integrating epidemiology and evolutionary biology, has become an essential tool in genomic epidemiological surveillance. It enables the estimation of epidemiological parameters, such as the reproductive number, from pathogen sequence data alone. Despite the phylodynamic approach being widely adopted, the abundance of phylodynamic models often makes it challenging to select the appropriate model for specific research questions. This article illustrates the application of phylodynamic birth-death-sampling models in public health using genomic data, with a focus on SARS-CoV-2. Targeting researchers less familiar with phylodynamics, it introduces a comprehensive workflow, including the conceptualisation of a research study and detailed steps for data preprocessing and postprocessing. In addition, we demonstrate the versatility of birth-death-sampling models through three case studies from Germany, utilising the BEAST2 software and its model implementations. Each case study addresses a distinct research question relevant not only to SARS-CoV-2 but also to other pathogens: Case study 1 finds traces of a superspreading event at the start of an early outbreak, exemplifying how simple models for genomic data can provide information that would otherwise only be accessible through extensive contact tracing. Case study 2 compares transmission dynamics in a nosocomial outbreak to community transmission, highlighting distinct dynamics through integrative analysis. Case study 3 investigates whether local transmission patterns align with national trends, demonstrating how phylodynamic models can disentangle complex population substructure with little additional information. For each case study, we emphasise critical points where model assumptions and data properties may misalign and outline appropriate validation assessments. Overall, we aim to provide researchers with examples on using birth-death-sampling models in genomic epidemiology, balancing theoretical and practical aspects.